Cargando…
HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice
Hepatocellular carcinoma (HCC) is one of the most common and deadly tumors worldwide. Management of HCC depends on reliable biomarkers for screening, diagnosis, and monitoring of the disease, as well as predicting response towards therapy and safety. To date, imaging has been the established standar...
Autores principales: | Schlosser, Sophie, Tümen, Deniz, Volz, Barbara, Neumeyer, Katja, Egler, Niklas, Kunst, Claudia, Tews, Hauke Christian, Schmid, Stephan, Kandulski, Arne, Müller, Martina, Gülow, Karsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742592/ https://www.ncbi.nlm.nih.gov/pubmed/36518320 http://dx.doi.org/10.3389/fonc.2022.1016952 |
Ejemplares similares
-
The Important Role of Protein Kinases in the p53 Sestrin Signaling Pathway
por: Gülow, Karsten, et al.
Publicado: (2023) -
Simultaneous Inhibition of Mcl-1 and Bcl-2 Induces Synergistic Cell Death in Hepatocellular Carcinoma
por: Michalski, Marlen, et al.
Publicado: (2023) -
Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose
por: Allgaier, Raphael, et al.
Publicado: (2023) -
Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma
por: Tümen, Deniz, et al.
Publicado: (2022) -
The Influence of Gut Microbiota on Oxidative Stress and the Immune System
por: Kunst, Claudia, et al.
Publicado: (2023)